The FDA’s new, same-old food labels demand better obesity solutions
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
WISH-TV on MSN14h
FDA redefines ‘healthy’ food labels to help consumers make informed choices
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
Rolling Out41m
Life-threatening allergen found in nation’s favorite snack
Urgent class 1 recall affects thousands of Lay's Classic Potato Chips bags due to undeclared milk allergen, posing severe health risks to sensitive consumers.
Frito Lay's Classic Potato Chips: Recall raised to highest risk level by FDA. What to know
The specifically recalled chips were: 13-ounce bags of Lay's Classic Potato Chips with UPC of 28400 31041, a "Guaranteed ...
MLive12h
This chocolate recall has been upgraded to FDA’s highest risk level
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
ABC712h
Red 3 banned from foods; why the FDA is pulling the dye from products
The FDA said manufacturers who use red three in food and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products.
Chocolate recall upgraded to highest risk level, FDA announces
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
The Return of Snake Oil
The Trump administration is poised to supercharge America’s appetite for supplements.
Recall alert: Chocolate-covered snacks, other items may cause ‘serious’ allergies
Chocolate- and yogurt-covered snacks made by Cal Yee Farm LLC could cause allergies not indicated on the label, the FDA warns ...
clinicaltrialsarena3h
MindMed doses first subject in Phase III Panorama study of GAD tablet
MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...